Regencell Bioscience Completes 38-for-1 Stock Split
Ticker: RGC · Form: 6-K · Filed: Jun 17, 2025 · CIK: 1829667
| Field | Detail |
|---|---|
| Company | Regencell Bioscience Holdings LTD (RGC) |
| Form Type | 6-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: stock-split, corporate-action
TL;DR
Regencell did a 38-for-1 stock split, no name/symbol change.
AI Summary
Regencell Bioscience Holdings Limited announced a 38-for-one forward stock split on June 2, 2025, effective for shareholders of record on that date. This split was distributed as a stock bonus, meaning shareholders received 37 additional shares for every share they owned. The company's name, CUSIP, and trading symbol remain unchanged.
Why It Matters
A stock split can make shares more accessible to a wider range of investors by lowering the per-share price, potentially increasing liquidity.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a stock split, which is a common corporate action with no inherent negative implications.
Key Numbers
- 38-for-one — Stock Split Ratio (Indicates the number of new shares issued for each existing share.)
Key Players & Entities
- Regencell Bioscience Holdings Limited (company) — The company announcing the stock split.
- June 2, 2025 (date) — The date the stock split was announced.
- 38-for-one (stock_split_ratio) — The ratio of the forward stock split.
FAQ
What was the effective date of the stock split?
The filing states the stock split was announced on June 2, 2025, and was effective for shareholders of record on that date.
How was the stock split implemented?
The stock split was implemented as a stock bonus, where shareholders received 37 additional shares for every share held on the record date.
Will Regencell's name or trading symbol change after the split?
No, the filing explicitly states there are no changes to the Company's name, CUSIP, or current trading symbol in connection with the forward stock split.
What is the purpose of a forward stock split?
While not explicitly stated as a purpose in this filing, forward stock splits are typically done to make shares more affordable and accessible to a broader investor base.
What is the filing type and its purpose?
This is a Form 6-K, which is a report of foreign private issuers required to be filed with the SEC for the month of June 2025, providing current information not otherwise required to be filed on a registration statement.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 17, 2025 regarding Regencell Bioscience Holdings Ltd (RGC).